Last 12 months
Inside the activity.
0 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 28, 2017 Filed Feb 9, 2017 21:02 UTC Amendment |
LaCasce Carl E.SVP, Sales & Marketing
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 12,472 | $0.00 Strike: $30.74 | $0.00 |
DisclosureSEC source: 0001214659-17-000915 · marketforms-37780.xml · derivative · entry 5 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,472 Underlying: Common Stock · 12,472 shares Expires 2022-02-13 F1 · shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F6 · derivative.exercise_date: Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 13, 2015 and the remaining vests monthly thereafter. F1 · derivative.underlying_shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F1 · balance_after: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:02 UTC Amendment |
LaCasce Carl E.SVP, Sales & Marketing
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 13,790 | $0.00 Strike: $27.77 | $0.00 |
DisclosureSEC source: 0001214659-17-000915 · marketforms-37780.xml · derivative · entry 4 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,790 Underlying: Common Stock · 13,790 shares Expires 2021-02-21 F1 · shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F5 · derivative.exercise_date: Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 21, 2014 and the remaining vests monthly thereafter. F1 · derivative.underlying_shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F1 · balance_after: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:02 UTC Amendment |
LaCasce Carl E.SVP, Sales & Marketing
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 13,530 | $0.00 Strike: $22.84 | $0.00 |
DisclosureSEC source: 0001214659-17-000915 · marketforms-37780.xml · derivative · entry 3 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,530 Underlying: Common Stock · 13,530 shares Expires 2019-11-09 F1 · shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F4 · derivative.exercise_date: Option fully vested three years from date of grant. F1 · derivative.underlying_shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F1 · balance_after: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:02 UTC Amendment |
LaCasce Carl E.SVP, Sales & Marketing
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 11,155 | $0.00 Strike: $19.21 | $0.00 |
DisclosureSEC source: 0001214659-17-000915 · marketforms-37780.xml · derivative · entry 2 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,155 Underlying: Common Stock · 11,155 shares Expires 2018-11-11 F1 · shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F3 · derivative.exercise_date: Option fully vested three years from date of grant. F1 · derivative.underlying_shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F1 · balance_after: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:02 UTC Amendment |
LaCasce Carl E.SVP, Sales & Marketing
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 18,089 | $0.00 Strike: $17.53 | $0.00 |
DisclosureSEC source: 0001214659-17-000915 · marketforms-37780.xml · derivative · entry 1 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,089 Underlying: Common Stock · 18,089 shares Expires 2017-05-14 F1 · shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F2 · derivative.exercise_date: Option fully vested three years from date of grant. F1 · derivative.underlying_shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F1 · balance_after: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:00 UTC Amendment |
NAUMANN-ETIENNE RUEDIGERDirector
|
GrantDeferred Stock Units · Derivative | 6,358 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000911 · marketforms-37814.xml · derivative · entry 3 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,329 Underlying: Common Stock · 6,358 shares Expires 2020-02-12 F1 · derivative.exercise_price: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "spin-off"), each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F1 · shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "spin-off"), each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F4 · derivative.exercise_date: These DSUs vest one year in four (4) equal quarterly installments over a 12 month period beginning February 12, 2016. Vested shares will be delivered the earlier of three (3) years from February 12, 2016 or termination date. F1 · derivative.underlying_shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "spin-off"), each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F1 · balance_after: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "spin-off"), each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:00 UTC Amendment |
NAUMANN-ETIENNE RUEDIGERDirector
|
GrantDeferred Stock Units · Derivative | 5,207 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000911 · marketforms-37814.xml · derivative · entry 2 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,329 Underlying: Common Stock · 5,207 shares Expires 2019-02-13 F1 · derivative.exercise_price: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "spin-off"), each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F1 · shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "spin-off"), each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F3 · derivative.exercise_date: These DSUs were fully vested on February 13, 2016. Vested shares will be delivered the earlier of three (3) years from February 13, 2015 or termination date. F1 · derivative.underlying_shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "spin-off"), each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F1 · balance_after: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "spin-off"), each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:00 UTC Amendment |
NAUMANN-ETIENNE RUEDIGERDirector
|
GrantDeferred Stock Units · Derivative | 5,764 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000911 · marketforms-37814.xml · derivative · entry 1 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,329 Underlying: Common Stock · 5,764 shares Expires 2018-02-21 F1 · derivative.exercise_price: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "spin-off"), each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F1 · shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "spin-off"), each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F2 · derivative.exercise_date: These DSUs were fully vested on February 21, 2015. Vested shares will be delivered the earlier of three (3) years from February 21, 2014 or termination date. F1 · derivative.underlying_shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "spin-off"), each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F1 · balance_after: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "spin-off"), each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:01 UTC Amendment |
REINHARDT ERICH RDirector
|
GrantDeferred Stock Units · Derivative | 6,358 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000912 · marketforms-37815.xml · derivative · entry 4 REINHARDT ERICH R · CIK 0001555958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,329 Underlying: Common Stock · 6,358 shares Expires 2020-02-12 F3 · derivative.exercise_price: In connection with the spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F3 · shares: In connection with the spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F6 · derivative.exercise_date: These DSUs vest one year in four (4) equal quarterly installments over a 12 month period beginning February 12, 2016. Vested shares will be delivered the earlier of three (3) years from February 12, 2016 or termination date. F6 · derivative.expiration_date: These DSUs vest one year in four (4) equal quarterly installments over a 12 month period beginning February 12, 2016. Vested shares will be delivered the earlier of three (3) years from February 12, 2016 or termination date. F3 · derivative.underlying_shares: In connection with the spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F3 · balance_after: In connection with the spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:01 UTC Amendment |
REINHARDT ERICH RDirector
|
GrantDeferred Stock Units · Derivative | 5,207 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000912 · marketforms-37815.xml · derivative · entry 3 REINHARDT ERICH R · CIK 0001555958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,329 Underlying: Common Stock · 5,207 shares Expires 2019-02-13 F3 · derivative.exercise_price: In connection with the spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F3 · shares: In connection with the spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F5 · derivative.exercise_date: These DSUs were fully vested on February 13, 2016. Vested shares will be delivered the earlier of three (3) years from February 13, 2015 or termination date. F5 · derivative.expiration_date: These DSUs were fully vested on February 13, 2016. Vested shares will be delivered the earlier of three (3) years from February 13, 2015 or termination date. F3 · derivative.underlying_shares: In connection with the spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F3 · balance_after: In connection with the spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:01 UTC Amendment |
REINHARDT ERICH RDirector
|
GrantDeferred Stock Units · Derivative | 5,764 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000912 · marketforms-37815.xml · derivative · entry 2 REINHARDT ERICH R · CIK 0001555958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,329 Underlying: Common Stock · 5,764 shares Expires 2018-02-21 F3 · derivative.exercise_price: In connection with the spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F3 · shares: In connection with the spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F4 · derivative.exercise_date: These DSUs were fully vested on February 21, 2015. Vested shares will be delivered the earlier of three (3) years from February 21, 2014 or termination date. F4 · derivative.expiration_date: These DSUs were fully vested on February 21, 2015. Vested shares will be delivered the earlier of three (3) years from February 21, 2014 or termination date. F3 · derivative.underlying_shares: In connection with the spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. F3 · balance_after: In connection with the spin-off, each outstanding deferred stock unit ("DSU") award held by the reporting person was converted into a DSU award denominated in shares of the Issuer's common stock. The number of shares underlying the DSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian DSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this DSU. Each DSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:01 UTC Amendment |
REINHARDT ERICH RDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 15,074 | $0.00 Strike: $23.24 | $0.00 |
DisclosureSEC source: 0001214659-17-000912 · marketforms-37815.xml · derivative · entry 1 REINHARDT ERICH R · CIK 0001555958 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,074 Underlying: Common Stock · 15,074 shares Expires 2020-02-15 F1 · shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F2 · derivative.exercise_date: Option vested 100% immediately on February 15, 2013. F1 · derivative.underlying_shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F1 · balance_after: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:02 UTC Amendment |
VERHOEF CLARENCE RSVP & Chief Financial Officer
|
GrantRestricted Stock Units · Derivative | 8,611 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000914 · marketforms-37818.xml · derivative · entry 7 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,830 Underlying: Common Stock · 8,611 shares Expires 2020-02-15 F6 · derivative.exercise_price: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F6 · shares: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F9 · derivative.exercise_date: These RSUs vest in three equal annual installments beginning on February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F9 · derivative.expiration_date: These RSUs vest in three equal annual installments beginning on February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F6 · derivative.underlying_shares: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F6 · balance_after: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:02 UTC Amendment |
VERHOEF CLARENCE RSVP & Chief Financial Officer
|
GrantRestricted Stock Units · Derivative | 3,618 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000914 · marketforms-37818.xml · derivative · entry 6 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,830 Underlying: Common Stock · 3,618 shares Expires 2019-02-15 F6 · derivative.exercise_price: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F6 · shares: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F8 · derivative.exercise_date: These RSUs vest in two equal annual installments beginning on February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F8 · derivative.expiration_date: These RSUs vest in two equal annual installments beginning on February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F6 · derivative.underlying_shares: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F6 · balance_after: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:02 UTC Amendment |
VERHOEF CLARENCE RSVP & Chief Financial Officer
|
GrantRestricted Stock Units · Derivative | 1,601 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000914 · marketforms-37818.xml · derivative · entry 5 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,830 Underlying: Common Stock · 1,601 shares Expires 2018-02-15 F6 · derivative.exercise_price: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F6 · shares: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F7 · derivative.exercise_date: These RSUs vest February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F7 · derivative.expiration_date: These RSUs vest February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F6 · derivative.underlying_shares: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F6 · balance_after: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:02 UTC Amendment |
VERHOEF CLARENCE RSVP & Chief Financial Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 47,786 | $0.00 Strike: $25.17 | $0.00 |
DisclosureSEC source: 0001214659-17-000914 · marketforms-37818.xml · derivative · entry 4 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,786 Underlying: Common Stock · 47,786 shares Expires 2023-02-12 F1 · shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F5 · derivative.exercise_date: Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 12, 2016 and the remaining vests monthly thereafter. F1 · derivative.underlying_shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F1 · balance_after: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:02 UTC Amendment |
VERHOEF CLARENCE RSVP & Chief Financial Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 27,116 | $0.00 Strike: $30.74 | $0.00 |
DisclosureSEC source: 0001214659-17-000914 · marketforms-37818.xml · derivative · entry 3 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,116 Underlying: Common Stock · 27,116 shares Expires 2022-02-13 F1 · shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F4 · derivative.exercise_date: Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 13, 2015 and the remaining vests monthly thereafter. F1 · derivative.underlying_shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F1 · balance_after: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:02 UTC Amendment |
VERHOEF CLARENCE RSVP & Chief Financial Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 22,063 | $0.00 Strike: $27.77 | $0.00 |
DisclosureSEC source: 0001214659-17-000914 · marketforms-37818.xml · derivative · entry 2 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,063 Underlying: Common Stock · 22,063 shares Expires 2021-02-21 F1 · shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F3 · derivative.exercise_date: Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 21, 2014 and the remaining vests monthly thereafter. F1 · derivative.underlying_shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F1 · balance_after: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:02 UTC Amendment |
VERHOEF CLARENCE RSVP & Chief Financial Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 21,047 | $0.00 Strike: $22.84 | $0.00 |
DisclosureSEC source: 0001214659-17-000914 · marketforms-37818.xml · derivative · entry 1 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,047 Underlying: Common Stock · 21,047 shares Expires 2019-11-09 F1 · shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F2 · derivative.exercise_date: Option fully vested three years from grant date. F1 · derivative.underlying_shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F1 · balance_after: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:01 UTC Amendment |
SANYAL SUNNYDirector · President and CEO
|
GrantRestricted Stock Units · Derivative | 8,267 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000913 · marketforms-37813.xml · derivative · entry 6 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,492 Underlying: Common Stock · 8,267 shares Expires 2020-02-15 F5 · derivative.exercise_price: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F5 · shares: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F8 · derivative.exercise_date: These RSUs vest in three equal annual installments beginning on February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.underlying_shares: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F5 · balance_after: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:01 UTC Amendment |
SANYAL SUNNYDirector · President and CEO
|
GrantRestricted Stock Units · Derivative | 9,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000913 · marketforms-37813.xml · derivative · entry 5 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,492 Underlying: Common Stock · 9,400 shares Expires 2019-02-15 F5 · derivative.exercise_price: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F5 · shares: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F7 · derivative.exercise_date: These RSUs vest in two equal annual installments beginning on February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.underlying_shares: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F5 · balance_after: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:01 UTC Amendment |
SANYAL SUNNYDirector · President and CEO
|
GrantRestricted Stock Units · Derivative | 5,825 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000913 · marketforms-37813.xml · derivative · entry 4 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,492 Underlying: Common Stock · 5,825 shares Expires 2018-02-15 F5 · derivative.exercise_price: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F5 · shares: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F6 · derivative.exercise_date: These RSUs vest February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.underlying_shares: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F5 · balance_after: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:01 UTC Amendment |
SANYAL SUNNYDirector · President and CEO
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 80,280 | $0.00 Strike: $25.17 | $0.00 |
DisclosureSEC source: 0001214659-17-000913 · marketforms-37813.xml · derivative · entry 3 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,280 Underlying: Common Stock · 80,280 shares Expires 2023-02-12 F1 · shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F4 · derivative.exercise_date: Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 12, 2016 and the remaining vests monthly thereafter. F1 · derivative.underlying_shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F1 · balance_after: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:01 UTC Amendment |
SANYAL SUNNYDirector · President and CEO
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 70,503 | $0.00 Strike: $30.74 | $0.00 |
DisclosureSEC source: 0001214659-17-000913 · marketforms-37813.xml · derivative · entry 2 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,503 Underlying: Common Stock · 70,503 shares Expires 2022-02-13 F1 · shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F3 · derivative.exercise_date: Option is subject to a three year vesting schedule, 1/3 of the total number of shares vested in one year from February 13, 2015 and the remaining vests monthly thereafter. F1 · derivative.underlying_shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F1 · balance_after: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. Read SEC document |
| January 28, 2017 Filed Feb 9, 2017 21:01 UTC Amendment |
SANYAL SUNNYDirector · President and CEO
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 161,330 | $0.00 Strike: $27.77 | $0.00 |
DisclosureSEC source: 0001214659-17-000913 · marketforms-37813.xml · derivative · entry 1 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,330 Underlying: Common Stock · 161,330 shares Expires 2021-02-21 F1 · shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F2 · derivative.exercise_date: Option is subject to a three year vesting schedule, 1/3 of the total number of shares vested in one year from February 21, 2014 and the remaining vests monthly thereafter. F1 · derivative.underlying_shares: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. F1 · balance_after: In connection with the spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. This amendment is being filed to disclose the exercise price and number of underlying shares that have been determined in respect of each grant. Read SEC document |
| January 20, 2017 Filed Nov 15, 2017 21:06 UTC |
Jonaitis Mark S.SVP and GM, X-Ray Sources
|
GrantCommon Stock | 13,288 | $28.15 | $374,057.20 |
DisclosureSEC source: 0001214659-17-006772 · marketforms-40118.xml · nonDerivative · entry 1 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,818 F1 · balance_after: The amount of securities beneficially owned has been updated to remove 6,530 shares inadvertently double counted in amount listed in the Form 4 filed on April 19, 2017 Read SEC document |
| January 20, 2017 Filed Nov 15, 2017 21:04 UTC |
LaCasce Carl E.SVP, Sales & Marketing
|
GrantCommon Stock | 6,328 | $28.15 | $178,133.20 |
DisclosureSEC source: 0001214659-17-006770 · marketforms-40122.xml · nonDerivative · entry 1 LaCasce Carl E. · CIK 0001695298 · SVP, Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,858 F1 · balance_after: These shares were acquired in connection with the company's separation from Varian Medical Systems, Inc. and were inadvertently omitted from column 5 in the Form 4 dated February 17, 2017. Read SEC document |
| January 20, 2017 Filed Nov 15, 2017 21:04 UTC |
VERHOEF CLARENCE RSVP & Chief Financial Officer
|
GrantCommon Stock | 2,230 | $28.15 | $62,774.50 |
DisclosureSEC source: 0001214659-17-006769 · marketforms-40121.xml · nonDerivative · entry 1 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,348 F1 · balance_after: These shares were acquired in connection with the company's separation from Varian Medical Systems, Inc. and were inadvertently omitted from column 5 in the Form 4 dated February 17, 2017. Read SEC document |
| January 20, 2017 Filed Nov 15, 2017 21:05 UTC |
SANYAL SUNNYDirector · President and CEO
|
GrantCommon Shares | 1,806 | $28.15 | $50,838.90 |
DisclosureSEC source: 0001214659-17-006771 · marketforms-40119.xml · nonDerivative · entry 1 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,595 F1 · balance_after: These shares were acquired in connection with the company's separation from Varian Medical Systems, Inc. and were inadvertently omitted from column 5 in the Form 4 dated February 17, 2017 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.